Skip to Content

Blincyto Prices, Coupons and Patient Assistance Programs

Blincyto (blinatumomab) is a member of the miscellaneous antineoplastics drug class and is commonly used for Acute Lymphoblastic Leukemia.

Blincyto Prices

The cost for Blincyto intravenous powder for injection 35 mcg is around $4,438 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Blincyto price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Intravenous Powder For Injection

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Blincyto Coupons and Rebates

Blincyto offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Blincyto Amgen First Step Program: Eligible commercially insured patients may pay only $5 per dose/cycle with savings of up to $10,000 per calendar year; $0 co-pay on 1st dose/cycle; for additional information contact the program at 888-657-8371.

Applies to:
Blincyto
Number of uses:
per prescription per calendar year

Form more information phone: 888-657-8371 or Visit website

Blincyto Amgen First Step Program Rebate: Eligible commercially insured patients who have already paid for treatment may request a rebate check; for additional information contact the program at 888-657-8371.

Applies to:
Blincyto
Number of uses:
One rebate per prescription fill

Form more information phone: 888-657-8371 or Visit website

Patient Assistance Programs for Blincyto

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Blincyto (blinatumomab) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Amgen FIRST STEP Co-Pay Support

Elligibility requirements:
  1. May have private/commercial insurance coverage (not a participant in federal or state-funded benefits program)
  2. Not Required
  3. Medically appropriate condition/diagnosis
  4. The patient must also be a US citizen.
  5. Health Care Providers must enroll in the program prior to processing the Amgen FIRST STEP Program Cards
Applicable drugs:
  • Blincyto (blinatumomab) Injection; IV

More information please phone: 888-657-8371 Visit Website

Provider: Amgen Safety Net Foundation (ASNF)

Elligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 500% of FPL
  3. *See Additional Information section below
  4. Yes, must have lived in the US or its territories for 6 months or longer.
  5. Please visit (www.SafetyNetFoundation.com) (www.AmgenAssist360.com) for more information. * Diagnosis is required if patient has insurance.
Applicable drugs:
  • Blincyto (blinatumomab) Injection; IV

More information please phone: 888-762-6436 Visit Website